Clinical trial
A Study To Evaluate PF-00915275 In Subjects With Type 2 Diabetes Mellitus For…
NCT00427401 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00427401 |
|---|---|
| Title | A Study To Evaluate PF-00915275 In Subjects With Type 2 Diabetes Mellitus For 4-Weeks |
| Official title | A Double Blind, Placebo Controlled, Parallel Group Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF-00915275 After Oral Administration To Subjects With Type 2 Diabetes Mellitus For 4-Weeks |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | PF-00915275 |
| Enrollment | 40 |
| Start date | Feb 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Jan 29, 2007 |
| Last update posted | Sep 29, 2008 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: